2 of Wall Street’s Favorite Stocks with Exciting Potential and 1 That Underwhelm
By:
StockStory
November 25, 2025 at 15:27 PM EST
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory. At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. Keeping that in mind, here are two stocks where Wall Street’s positive outlook is supported by strong fundamentals and one where consensus estimates seem disconnected from reality. One Stock to Sell:F.N.B. Corporation (FNB)Consensus Price Target: $18.79 (12.3% implied return) Tracing its roots back to 1864 during the Civil War era, F.N.B. Corporation (NYSE: FNB) is a diversified financial services holding company that provides banking, wealth management, and insurance services to consumers and businesses across seven states and Washington, D.C. Why Does FNB Give Us Pause?
At $16.74 per share, F.N.B. Corporation trades at 0.9x forward P/B. If you’re considering FNB for your portfolio, see our FREE research report to learn more. Two Stocks to Watch:Intuit (INTU)Consensus Price Target: $804.22 (23.5% implied return) Originally named after its founding product "Intuitive for the first-time user," Intuit (NASDAQ: INTU) provides financial management software and services including TurboTax, QuickBooks, Credit Karma, and Mailchimp to help consumers and small businesses manage their finances. Why Are We Fans of INTU?
Intuit is trading at $650.99 per share, or 8.4x forward price-to-sales. Is now the right time to buy? Find out in our full research report, it’s free for active Edge members. Humana (HUM)Consensus Price Target: $287.92 (21.4% implied return) With over 80% of its revenue derived from federal government contracts, Humana (NYSE: HUM) provides health insurance plans and healthcare services to approximately 17 million members, with a strong focus on Medicare Advantage plans for seniors. Why Does HUM Stand Out?
Humana’s stock price of $237.15 implies a valuation ratio of 17.1x forward P/E. Is now a good time to buy? See for yourself in our in-depth research report, it’s free for active Edge members. High-Quality Stocks for All Market ConditionsYour portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily. The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. More NewsView More
Five Below and Dollar Tree Earnings Signal a Shopper Shift ↗
Today 7:15 EST
Via MarketBeat
Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead? ↗
December 06, 2025
Via MarketBeat
Tickers
ULTA
Gates Foundation Sells MSFT Stock—Should Investors Be Worried? ↗
December 06, 2025
Via MarketBeat
Tickers
MSFT
MarketBeat Week in Review – 12/1 - 12/5 ↗
December 06, 2025
Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift ↗
December 05, 2025
Via MarketBeat
Tickers
RKLB
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
